Eleven Biotherapeutics Inc. (Nasdaq: EBIO) narrowed losses for the second quarter to 36 cents per share from 51 cents per share in the year ago period. The stock price gained 77 cents to $4.86.
Eleven Biotherapeutics narrows losses
August 13, 2015 at 15:19 PM EDT
